Enhancing Immunogenicity of a Thermostable, Efficacious SARS-CoV-2 Vaccine Formulation through Oligomerization and Adjuvant Choice.

Khan MS, Jakob V, Singh R, Rajmani RS, Kumar S, Lemoine C, Kleanthous H, Ringe RP, Dubois PM, Varadarajan R

DOI: 10.3390/pharmaceutics15122759
Published: 2023 Dec 12
Container: Pharmaceutics
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics15122759,
  title = {Enhancing Immunogenicity of a Thermostable, Efficacious SARS-CoV-2 Vaccine Formulation through Oligomerization and Adjuvant Choice.},
  author = {Khan MS and Jakob V and Singh R and Rajmani RS and Kumar S and Lemoine C and Kleanthous H and Ringe RP and Dubois PM and Varadarajan R},
  year = {2023},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics15122759},
  url = {https://doi.org/10.3390/pharmaceutics15122759}
}

RIS

TY  - JOUR
TI  - Enhancing Immunogenicity of a Thermostable, Efficacious SARS-CoV-2 Vaccine Formulation through Oligomerization and Adjuvant Choice.
AU  - Khan MS
AU  - Jakob V
AU  - Singh R
AU  - Rajmani RS
AU  - Kumar S
AU  - Lemoine C
AU  - Kleanthous H
AU  - Ringe RP
AU  - Dubois PM
AU  - Varadarajan R
PY  - 2023
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics15122759
UR  - https://doi.org/10.3390/pharmaceutics15122759
ER  -

APA

MS, K., V, J., R, S., RS, R., S, K., C, L., H, K., RP, R., PM, D., & R, V. (2023). Enhancing Immunogenicity of a Thermostable, Efficacious SARS-CoV-2 Vaccine Formulation through Oligomerization and Adjuvant Choice.. Pharmaceutics. https://doi.org/10.3390/pharmaceutics15122759

Source records

pubmed · retrieved 2026-09-26T05:41:14.701Z